A cost-effectiveness analysis of the Chlamydia Monday - A community-based intervention to decrease the prevalence of chlamydia in Sweden

Scandinavian Journal of Public Health

Volumn 38, Issue 2, 2010, Pages 141-150

  Deogan, Charlotte L ^a   Månsdotter, Anna M ^a   Hansson Bocangel, Marta K ^b   Wamala, Sarah P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

Chlamydia trachomatis; cost; cost effectiveness; intervention; PID; QALY; saving; screening

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTACT EXAMINATION; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE TRANSMISSION; ECONOMICS; FEMALE; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; METHODOLOGY; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SWEDEN; UNSAFE SEX;

ADOLESCENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMMUNICABLE DISEASE CONTROL; CONTACT TRACING; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWEDEN; UNSAFE SEX; YOUNG ADULT;

EID: 77949326173     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494809357260     Document Type: Article

References (37)

1. Swedish Institute of Infectious Disease Control [online]. 2007. Available from: http://www.smittskyddsinstitutet.se/statistik/klamydiainfektion (accessed 29 August 2009).
2. Nusbaum R.H.M., Wallace R.R., Slatt M.L., Konrad C.E. Sexually transmitted infections and increased risk of co-infection with Human Immunodeficiency Virus. J Am Osteopathic Ass 2004;104:527-535.
3. Drummond M.F., Sculpher M.J., Torrance G.W., O’Brien BJ, Stoddart G.L. Methods for the economic evaluation of health care programmes, 3rd edn. Oxford: Oxford University Press; 2005.
4. Swedish National Institute of Public Health. Health economics for public health sciences - Introduction and debate. Stockholm: Swedish National Institute of Public Health; 2003.
5. Buhaug H., Skjeldestad F.E., Backe B., Dalen A. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care 1989;27(8):833-841.
6. Adams E.J., Turner K.M.E., Edmunds W.J., Roberts T.E., Low N. The cost effectiveness of opportunistic Chlamydia screening in England. Sex Transm Inf 2007;83:267-275.
7. Welte R., Kretschmar M., Leidl R., van den Hoek A., Jager J.C., Postma M.J. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population based dynamic approach. Sex Transm Dis 2000; 27:518-529.
8. Townshend J.R.P., Turner H.S. Analyzing the effectiveness of Chlamydia screening. J Operational Res Soc 2000; 51:812-824.
9. Hu D., Hook 3rd EW, Goldie S.J. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Int Med 2004;141:501-513.
10. Novak D.P., Lindholm L., Jonsson M., Karlsson R.B. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home. Scand J Public Health 2004; 32:324-332.
11. Chen M.Y., Karvelas M., Sundararajan V., Hocking J.S., Fairley C.K. Evidence for the effectiveness of a Chlamydia awareness campaign: increased population rates of Chlamydia testing and detection. Int J STD AIDS 2007;18:239-243.
12. Oh M.K., Grimley D.M., Merchant J.S., Brown P.R., Cecil H., Hook E.W. Mass media as a population-level intervention tool for Chlamydia trachomatis screening: report of a pilot study. J Adolesc Health 2002;31:40-47.
13. Andersen B., stergaard L., Moller J.K., Olesen F. Effectiveness of a mass media campaign to recruit young adults for testing of Chlamydia trachomatis by use of home obtained and mailed samples. Sex Transm Inf 2001;77:416-418.
14. Gift T.L., Blake D.R., Gaydos C.A., Marrazzo J.M. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2008;35(11 suppl): S51-S60.
15. Roberts T.E., Robinson S., Barton P., Bryan S., Low N. Screening for Chlamydia trachomatis: a systematic review of economic evaluations and modeling. Sex Transm Inf 2006;82:193-200.
16. Turner M.E., Adams E.J., Gay N., Ghani A.C., Mercer C., Edmunds W.J. Developing a realistic sexual network model of Chlamydia transmission in Britain. Theoretical Biology and Medical Modelling 2006;3:3.
17. Swedish Dental and Pharmaceutical Benefits Agency. Pharmaceutical Benefits Boards general guidelines for economic evaluations LFNAR 2003:2 [online]. 2009. Available from: http://www.tlv.se/Upload/Lagar_och_foreskrifter/LAG-lfnar-2003-2.pdf (accessed 10 December 2009).
18. The Swedish Association of Health Professionals [online]. 2008. Tillgänglig. http://www.vardforbundet.se/templates/VFArticlePage4.aspx?id=18457 (accessed 10 August 2009).
19. Swedish National Tax Board [online]. 2008. Available from: http://www.skatteverket.se/fordigsomar/arbetsgivareinfotxt/socialavgifter.4.18e1b10334ebe8bc80005862.html (accessed 5 August 2009).
20. Stockholm Unit of Infectious Disease Control [online]. 2006. Medverkan 2005 Available from: http://webbhotell.sll.se/Global/Smittskyddsenheten/Dokument/Diverse/medverkan2005.pdf (accessed 5 August 2009).
21. Swedish Pharmaceutical Benefits Board [online]. 2008 Available from: http://www.lfn.se/LFNTemplates/ProductMedSearch.aspx?id=385 (accessed 21 August 2009).
22. Statistics Sweden [online]. 2006. Available from: http://www.scb.se/templates/pressinfo____178714.asp (accessed 5 August 2009).
23. Howell M.R., Gaydos J.C., McKee Jr KT, Quinn T.C., Gaydos C.A. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999;26:519-526.
24. van Valkengoed Irene G.M., Postma Maarten J., Morré Servaas A., van den Brule Adriaan JC, Meijer C.J., et al. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex Transm Inf 2001;77:276-282.
25. Randolph A.G., Washington A.E. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis. Am J Public Health 1990;80:545-550.
26. Blake D.R., Gaudos C.A., Quinn T.C. Cost-effectiveness of screening adolescent males for Chlamydia on admission to detention. Sex Transm Dis 2004; 31(2):85-95.
27. Appendix 2: Chlamydia. In: Stratton KR, Durch JS, Lawrence RS, editors. Vaccines for the 21st century: a tool for decision making. Washington, DC: National Academy Press; 2000. pp. 149-158.
28. Feeny D. The Health Utilities Index: a tool for assessing health benefits. Patient-Reported Outcome Newsletter 2005;34:2-6.
29. Carré H., Boman J., Österlund A., Gärdén B., Nylander-Lundqvist E. Improved contact tracing for Chlamydia trachomatis with experienced tracers, tracing for one year back in time and interviewing by phone in remote areas. Sex Transm Inf 2008;84:239-242.
30. Swedish National Board of Health and Welfare. Guidelines for Cardiac Care, 2008. Appendix 2. 2008. Available from: http://www.socialstyrelsen.se/NR/rdonlyres/ED85322A-C017-473BBF36-D6337EB166A1/10018/20081027_bilaga_991.pdf (accessed 15 August 2009).
31. Duncan B., Hart G. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ 1999; 318:931-3.
32. Ajzen I., Brown T.C., Carvajal F. Explaining the discrepancy between intentions and actions: the case of hypothetical bias in contingent valuation. Pers Soc Psychol Bull 2004;30:1108.
33. Folland S., Goodman A.C., Stano M. The economics of health and health care, 3rd edn. New Jersey: Prentice Hall; 1993.
34. Janssen R. Time prices and the demand for GP services. Soc Sci Med 1992;34:725-733.
35. Wedig, G.J. Health status and the demand for health: results on price elasticities. J Health Economics 1988;7:151-163.
36. Idahl A., Boman J., Kumlin U., Olofsson J.I. Demonstration of Chlamydia trachomatis lgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy. Human Reprod 2004;19:1121-6.
37. Martius J., Krohn M.A., Hillier S.L., Stamm W.E., Holmes K.K., Eschenbach D.A. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988;71:89-95.